Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Open-label IC41 therapeutic HCV vaccine in chronic hepatitis C
2006-002034-37Phase 2Completed
- Sponsor
- Intercell AG
- Start
- May 2006
- Modality
- Vaccines & Immunotherapeutics, Recombinant Proteins and Enzymes, Peptides
- Countries
- 1
01
Overview
Phase 2, open-label trial of IC41 in hepatitis C virus infection (2 arms), sponsored by Intercell AG. Primary endpoint: Primary virological endpoint. Started May 2006; status: completed.
02
Drugs
IC41
03
Conditions
hepatitis C virus infection
Beyond the preview
Go deeper on 2006-002034-37.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-002034-37.